Early response to therapy and outcome in childhood acute lymphoblastic leukemia

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

1994 • 631 citations

Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals

1995 • 481 citations

Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance [see comments]

1995 • 452 citations

Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals

1995 • 426 citations

Prognostic factors in osteosarcoma: a critical review.

1994 • 424 citations

Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators

1991 • 369 citations

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X

1995 • 286 citations

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1994 • 276 citations

Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)

1987 • 266 citations

Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission

1994 • 241 citations

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1993 • 229 citations

The Molecular Basis of Leukemia

1994 • 210 citations

Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.

1993 • 193 citations

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

1996 • 185 citations

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.

1986 • 178 citations

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia

1995 • 173 citations

Factors related to length of complete remission in adult acute leukemia

1980 • 171 citations

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.

1990 • 164 citations

The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma.

1991 • 153 citations

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group

1983 • 146 citations

Analysis of prognostic factors in acute lymphoblastic leukemia

1986 • 133 citations

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

1989 • 114 citations

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

1990 • 110 citations

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.

1992 • 104 citations

Therapy Results in Five ALL-BFM Studies Since 1970: Implications of Risk Factors for Prognosis

1987 • 104 citations

Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark

1994 • 95 citations

Pretransplantation Burden of Leukemic Progenitor Cells as a Predictor of Relapse after Bone Marrow Transplantation for Acute Lymphoblastic Leukemia

1993 • 95 citations

WHICH TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA IN SECOND REMISSION?

1987 • 91 citations

Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).

1973 • 89 citations

Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia

1995 • 85 citations

Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.

1994 • 65 citations

Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.

1980 • 56 citations

Genomic Imprinting, DNA Methylation, and Cancer

1994 • 53 citations

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review.

1994 • 49 citations

Genomic Imprinting, DNA Methylation, and Cancer

1994 • 48 citations

Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.

1994 • 44 citations

Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia

1988 • 42 citations

Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: The state of the art

1994 • 36 citations

LSA2-L2 protocol treatment of stage IV non-hodgkin's lymphoma in children with partial and extensive bone marrow involvement

2006 • 35 citations

Molecular basis for the human erythrocyte glycophorin specifying the Miltenberger class I (MiI) phenotype

1992 • 25 citations

Minimal Residual Disease in Acute Leukemia:Lessons Learned from Animal Models

1990 • 2 citations